NAN

NANOSONICS FPO [NAN]
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Healthcare · ASX Small Cap
$2.7500 +2.2%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-04
Get alerts when NAN triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track NAN — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Volume surging at 2.6x normal while price climbs — real buying conviction behind this move
  • Lagging the Small Ords index — relative strength of 0.79, underperforming its peers
  • Cash positive / operating cashflow positive
  • Low P/S ratio (4.0x)
  • Piotroski F-Score strong (7/9, low-confidence approx)
  • EPS estimates revised upward (+3pts)
  • Near 52-week low (6% of range)
  • Elevated short interest (7.4%)
  • Earnings in sharp decline (-25% QoQ)
  • CANSLIM I: Institutional ownership (65%)
  • Sentiment is mixed — no strong consensus either way
  • Days to cover very high (15.8)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Earnings momentum has turned negative — worth checking what's behind it
  • The bigger volume days are the down days — volume-weighted momentum is negative (-2.74%/day)
Ask Scout AI about NAN
"What's driving NAN today?" "How does NAN compare to peers?" "Key risks for NAN?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification of cessation of securities - NAN
NONE Cancel - Notification of cessation of securities - NAN
NONE Change of Director's Interest Notice

Recent ASX Announcements

2026-08-28 Notification of cessation of securities - NAN
2026-08-28 Cancel - Notification of cessation of securities - NAN
2026-08-28 Change of Director's Interest Notice
2026-08-26 Notification of buy-back - NAN
2026-08-24 Appendix 4G

Key Metrics

$825.0M
Market Cap
1.4M
Avg Volume
2.6x
Vol Ratio
$2.64 — $4.76
52-Week Range
7.4%
Short Interest
N/A
Cash Runway
8.3%
ROE
8.7%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: -25%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 84%
LLeader vs LaggardlaggardRS: -9
IInstitutional SponsorshippassInst: 65%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
REG -27.0%CAN +25.0%BIT -20.0%MEM +20.0%CMP -14.6%
Compare:NAN vs REGNAN vs CANNAN vs BIT
Scout Pro — Deeper Analysis for NAN
Try Pro free for 30 days
Share this analysis

Track NAN and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required